The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system. This was discovered by scientists at the German Cancer Research Center (DKFZ) and the Berlin Institute of Health (BIH). The enzyme that activates the dioxin receptor is produced in large quantities by tumor cells. In the future, substances that inhibit IL4I1 could open up new opportunities for cancer therapy. The scientists have now published their results in the journal Cell.
- Volunteers receiving government aid while unemployed face scrutiny, bias from public
- The testimony of trees: How volcanic eruptions shaped 2000 years of world history
- Building walls that will make summer heat waves more bearable
- How hormone therapy slows progression of atherosclerosis
- Could your menopause symptoms be hard on your heart?